INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

To provide compositions and methods for treating human immunodeficiency virus (HIV) infection.SOLUTION: The invention provides compounds of a formula I, including pharmaceutically acceptable salts thereof. (In the formula, R0, R1 and R2 are each independently hydrogen, Cl, F, -OMe, -CN, -C1-C3 alkyl...

Full description

Saved in:
Bibliographic Details
Main Authors SELVAKUMAR KUMARAVEL, B NARASIMHULU NAIDU, MANOJ PATEL, JOHN A BENDER, SURESH BABU, PULICHARLA NAGALAKSHMI, CHRISTIANA IWUAGWU, JOHN F KADOW, RAMKUMAR RAJAMANI, MARK SAULNIER, ALAN XIANGDONG WANG, MAKONEN BELEMA, KEVIN M PEESE
Format Patent
LanguageEnglish
Japanese
Published 27.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide compositions and methods for treating human immunodeficiency virus (HIV) infection.SOLUTION: The invention provides compounds of a formula I, including pharmaceutically acceptable salts thereof. (In the formula, R0, R1 and R2 are each independently hydrogen, Cl, F, -OMe, -CN, -C1-C3 alkyl, or -C3-C5 cycloalkyl, where -C1-C3 alkyl may be optionally substituted with 1-3 fluorine atoms, and Q and W represent specific heterocyclic groups.)SELECTED DRAWING: None 【課題】ヒト免疫不全ウイルス（ＨＩＶ）感染を処置するための組成物及び方法を提供する。【解決手段】式Ｉの化合物（その薬学的に許容される塩を含む）を提供する。JPEG2023088942000669.jpg3131(式中、R0、R1、及びR2は、各々独立して水素、Cl、F、-OMe、-CN、-C1～C3アルキル、又は-C3～C5シクロアルキルであり、ここで-C1～C3アルキルは場合により1～3個のフッ素で置換されていてもよく、QおよびWは、特定の複素環基を表す)【選択図】なし
Bibliography:Application Number: JP20230040530